|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/12 | |
| C07D 491/107 | |||
| A61K 9/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2958895 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14754329.2 |
| Date of filing the European patent application | 2014-02-20 | |
| (97) | Date of publication of the European application | 2015-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/017270 |
| Date | 2014-02-20 |
| (87) | Number | WO 2014/130612 |
| Date | 2014-08-28 |
| (30) | Number | Date | Country code |
| 201361767087 P | 2013-02-20 | US | |
| 201361898741 P | 2013-11-01 | US |
| (72) |
ONG, Winston Zapanta, US
NOWAK, Pawel Wojciech, US
ASKEW, Ben C., US
KIM, Jinsoo, US
|
| (73) |
Kala Pharmaceuticals, Inc.,
490 Arsenal Way, Suite 120, Watertown, MA 02472,
US
|
| (54) | THERAPEUTIC COMPOUNDS AND USES THEREOF |
| THERAPEUTIC COMPOUNDS AND USES THEREOF |